Skip to main content
    P

    Psyence Biomedical Ltd. Common Shares (PBM)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $4.32
    +0.19 (+4.60%)

    Market Cap: $15.75M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    PeriodReportedEst.SurpriseB/MYoY
    Jun 26
    Reported Sep 28
    		$N/AN/AN/ABeat-
    Sep 25
    Reported Nov 20
    		$-0.51$0.00N/AMiss+3.1%
    Mar 25
    Reported Jun 25
    		$-99.97$0.00N/AMiss-204337.6%
    Dec 24
    Reported Jan 23
    		$4.06$0.00N/ABeat+30398.5%
    Sep 24
    Reported Sep 30
    		$0.04N/AN/ABeat-14.8%
    Sep 23
    Reported Sep 30
    		$-0.53N/AN/ABeat-1854.0%
    Jun 23
    Reported Jun 30
    		$-0.05N/AN/ABeat-169.9%
    Mar 23
    Reported Mar 31
    		$-0.01N/AN/ABeat-105.4%
    Dec 22
    Reported Mar 23
    		$0.05N/AN/ABeat-96.9%
    Sep 22
    Reported Nov 14
    		$0.03N/AN/ABeat-88.0%
    Jun 22
    Reported Aug 15
    		$0.07N/AN/ABeat-
    Mar 22
    Reported Apr 1
    		$0.25N/AN/ABeat-
    Dec 21
    Reported Dec 31
    		$1.59N/AN/ABeat-
    Sep 21
    Reported Oct 21
    		$0.25$0.00N/ABeat-

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-58.60%ROICN/A
    Financial Health
    Debt/Equity0.00xInterest Coverage110.15x
    Current Ratio8.09xQuick Ratio8.09x
    Trading Statistics
    Beta1.69Avg Volume79.93K
    52-Week High$22.2552-Week Low$1.92

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$4.80
    SMA 20$5.35
    SMA 50$4.78
    SMA 200$5.66
    EMA 10$4.76
    EMA 20$4.99
    EMA 50$4.82
    EMA 200$21.52

    MACD

    Line: -0.16Signal: 0.03Hist: -0.19

    ADX

    ADX: 32.7+DI: 15.1-DI: 24.2

    Aroon & PSAR

    Aroon Up36.0
    Aroon Down100.0
    PSAR$5.02

    Bollinger Bands

    Upper Band$6.73
    Lower Band$3.96
    %B Position5179%(Upper)
    Band Width0.13

    RSI (14-Day)

    Neutral
    37.4

    Momentum Oscillators

    Stoch %K5.0
    Stoch %D2.6
    Williams %R-86.7
    ROC (10d)-21.2%
    Momentum-1.16
    CCI (20d)-138.5
    MFI (14d)21.6

    Volatility Measures

    ATR (14d)$0.44(10.2%)
    StdDev (20d)0.69
    Hist Vol66.6%(High)

    Volume Flow

    VWAP$4.28
    OBV91.2M
    AD Line69.4B
    CMF (20d)-0.380

    Volume Metrics

    Avg Vol (20d)79.2K
    Vol Ratio0.2x(Low)
    VWMA (20d)$5.71

    Pivot Points

    R3$5.32
    R2$5.07
    R1$4.60
    Pivot Point$4.35
    S1$3.88
    S2$3.63
    S3$3.16

    Advanced Oscillators

    TSI-10.91
    Ultimate Osc26.3
    KST10.08

    Financial Data

    QuarterSep 2025Dec 2024Sep 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021
    Total Revenue$0N/A$0N/A$0N/AN/AN/AN/AN/AN/AN/A
    Cost of Revenue$1,330$1,016N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
    Gross Profit$-1,330$-1,016N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
    Operating Expenses$1.50M$1.16M$1.16M$632,103$754,379$512,088$771,493$1.74M$-281,458$293,016$326,902$254,795
    R&D$357,444$265,626$265,626$75,136$8,539$0$0$977,916$1,852$0$0$0
    SG&A$1.15M$616,708$890,476$517,743$183,607$0$0$0$242,145$0$0$0
    Operating Income$-1,506,307$-1,157,118$-1,157,118$-632,103$-176,165$-678,395$-1,043,468$-510,930$-243,998$-293,020$-326,900$-254,800
    Interest Income$72,815$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$2,753$3,715$3,715$11,469$27,568$0$0$0$669$0$0$0
    Income Before Tax$-753,254$141,473$141,473$-24,763,242$-309,682$-62,842$-24,489$2.25M$-244,667$2.04M$2.95M$8.31M
    Income Tax Expense$0$0$0$-118$0$0$0$0$0$0$0$0
    Net Income$-753,254$141,473$141,473$-24,763,242$-877,224$-62,842$-24,489$2.25M$766,838$2.04M$2.95M$8.31M
    EBITDA$-749,168$146,204N/AN/A$-877,224N/A$-33,122$3.02M$1.05M$2.63M$3.69M$10.59M
    EBIT$-750,498$145,188$-1,157,118$-632,221$-557,050$-512,090$-771,490$-510,930$-163,130$-293,020$-326,900$-254,800
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about PBM

    PBM Valuation and Fair Value

    P/B
    0.5x
    See GNG's fair value

    PBM Profitability: Margins, ROIC and FCF

    Operating margin
    0.0%
    Net margin
    0.0%
    ROE
    -58.6%

    PBM Competitors

    CompanyTicker
    Concord Medical Services HoldingsCCM
    Cyclerion Therapeutics IncCYCN
    Dyadic International IncDYAI
    Heart Test Laboratories Inc. Common StockHSCS
    Jasper Therapeutics IncJSPR
    Biocardia IncBCDA
    Quantum BioPharma Ltd.QNTM
    Marker Therapeutics IncMRKR

    Sector: Healthcare

    PBM Earnings: Beat Rate and Next Report

    Beat rate
    2 of 4 quarters (50.0%)

    Frequently Asked Questions About PBM

    Does PBM pay dividends?

    Psyence Biomedical Ltd. Common Shares (PBM) does not currently pay a regular dividend.

    What is PBM's market cap?

    Psyence Biomedical Ltd. Common Shares (PBM) has a market capitalization of $15.75M with a current stock price of $4.32.

    Related stocks

    Sector: Healthcare

    All stocks starting with P

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In